Clincosm LogoSign in Get a demo

PETANC: Comparison of Tumor Glucose Metabolism Before and After Artificial Nutrition

Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle (Other)
Overall Status
Completed
CT.gov ID
NCT02382237
Collaborator
(none)
20
Enrollment
1
Location
1
Arm
46.3
Actual Duration (Months)
0.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Evaluate the feasability to determine the difference of tumoral metabolism before and after artificial nutrition.

Condition or Disease Intervention/Treatment Phase
  • Device: PET/TDM
 N/A

Detailed Description

Evaluation of the feasability to determine the difference of tumoral metabolism before and after artificial nutrition. This activity will be measured with TEP/TDM 18F-FDG

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Comparison of Tumor Glucose Metabolism Before and After Artificial Nutrition Assessed by F-FDG Petscan
Actual Study Start Date :
Oct 1, 2013
Actual Primary Completion Date :
Nov 1, 2015
Actual Study Completion Date :
Aug 9, 2017

Arms and Interventions

Arm Intervention/Treatment
Other: PET/TDM

Evaluation by PET/TDM at 2 times

Device: PET/TDM
Evaluation of nutrition absorption by TEP/TDM
Other Names:
  • Parenteral or enteral nutrition

    		•

    Outcome Measures

    Primary Outcome Measures

    1. rate of Standardized Uptake Value (SUV) [3 months]

      The variation of the SUVmax is defined as the difference of the tumoral SUV max between the TEP1 and the TEP2

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • VADS cancer or oesophageal cancer

    • Evaluation by 18F-FDG PET

    • denutrition with weight loss of 5%

    • Artificial nutrition

    • ECOG<2

    Exclusion Criteria:

    • Treatment by chemotherapy, surgery unless 2 months

    • Treatment by radiotherapy unless 4 months

    • Capillar glycemia >12mmol/l during the PET

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 ICM Val d'Aurelle Montpellier France 34298

    Sponsors and Collaborators

    • Institut du Cancer de Montpellier - Val d'Aurelle

    Investigators

    • Principal Investigator: DESHAYES Emmanuel, ICM Co. Ltd.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Institut du Cancer de Montpellier - Val d'Aurelle
    ClinicalTrials.gov Identifier:
    NCT02382237
    Other Study ID Numbers:
    • ICM2013/31
    First Posted:
    Mar 6, 2015
    Last Update Posted:
    Aug 21, 2017
    Last Verified:
    Aug 1, 2017
    Keywords provided by Institut du Cancer de Montpellier - Val d'Aurelle
    denutrition in Head and Neck cancer or oesophageal cancer
    Additional relevant MeSH terms:
    Head and Neck Neoplasms

    Study Results

    No Results Posted as of Aug 21, 2017